Correlation of serum proteomics patterns of sCD200 (OX-2), sApo-2L (sTRAIL), vitamin-D and homocysteine to quantitative FDG-PET/CT findings in newly diagnosed non-small cell lung cancer

J BUON. 2013 Oct-Dec;18(4):1099-100.

Authors

A Bisgnin¹, A D Yalcin, S Gumuslu, B Kargi, A Kargi, B Savas, L G Strauss

Affiliation

¹ Cukurova University, Faculty of Medicine, Dept of Medical Genetics of Balcali Clinics and Hospitals, Adana, Turkey.

PMID: 24344047

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD / blood*
Biomarkers, Tumor / blood
Carcinoma, Non-Small-Cell Lung / blood*
Carcinoma, Non-Small-Cell Lung / diagnosis*
Carcinoma, Non-Small-Cell Lung / diagnostic imaging
Carcinoma, Non-Small-Cell Lung / mortality
Carcinoma, Non-Small-Cell Lung / pathology
Carcinoma, Non-Small-Cell Lung / therapy
Enzyme-Linked Immunosorbent Assay
Fluorodeoxyglucose F18* / pharmacokinetics
Homocysteine / blood*
Humans
Linear Models
Lung Neoplasms / blood*
Lung Neoplasms / diagnosis*
Lung Neoplasms / diagnostic imaging
Lung Neoplasms / mortality
Lung Neoplasms / pathology
Lung Neoplasms / therapy
Multimodal Imaging
Positron-Emission Tomography*
Predictive Value of Tests
Prognosis
Proteomics* / methods
Radiopharmaceuticals* / pharmacokinetics
Survival Analysis
TNF-Related Apoptosis-Inducing Ligand / blood*
Tomography, X-Ray Computed*
Vitamin D / analogs & derivatives*
Vitamin D / blood
Whole Body Imaging

Substances

Antigens, CD
Biomarkers, Tumor
Radiopharmaceuticals
TNF-Related Apoptosis-Inducing Ligand
TNFSF10 protein, human
Homocysteine
Fluorodeoxyglucose F18
Vitamin D
1,25-dihydroxyvitamin D
antigens, CD200